To study the efficacy of Yastimadhu Daruharidra Kwath Aschyotana and opticure eye drop in management of Sirotpat

Randomized controlled clinical trial to study the efficacy of Yastimadhu Daruharidra Kwath Aschyotana and opticure eye drop in the management of Sirotpat

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/02/040490

Enrollment

Registered

2022-02-22

Start date

Unknown

Completion date

Unknown

Last updated

2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H102- Other acute conjunctivitis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patient suffering from Sirotpat having at least 3 classical symptoms of sirotpat 1. Redness 2. Sirajaladarshan 3. Daha (burning sensation) 4. Pain

Exclusion criteria

Exclusion criteria: 1.Patient with episcleritis, corneal injury, corneal ulcer, keratitis, iridocyclitis 2.Immunocompromised patients 3. Patients with contagious diseases, malignancies

Design outcomes

Primary

Measure	Time frame
To study the efficacy of Yastimadhu Daruharidra Kwath Aschyotana and opticure eye drop in the management of SirotpatTimepoint: 7 to 10 days	—

Secondary

Measure	Time frame
To compare the effect of yastimadhu daruharidra kwath aschyotana and opticure eye drop.Timepoint: 7to 10 days	—

Countries

India

Contacts

Public ContactDr Rekha Munjabhau Mahatme

Tilak Ayurveda Mahavidyalaya, Pune

salvisangeeta@yahoo.co.in9822082795

Outcome results